3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
8
Recruiting
4
Unknown
3
Terminated
1
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
OTHER
4
Study Type
Observational
2
Interventional
2
Sponsor
Cancer Type
Thoracic
16
Other
4
Other hematologic neoplasm
2
Lymphoid
1
Genitourinary
1
Conditions
Obesity
60
Neoplasms
20
Overweight
17
Polycystic Ovary Syndrome
11
Dyspnea
10
Sexual Dysfunction, Physiological
9
Prostatic Neoplasms
7
Motor Activity
7
Hypertension
7
Endometrial Neoplasms
7
Breast Neoplasms
7
Diabetes Mellitus, Type 2
6
Mucositis
5
Metabolic Syndrome
5
Diabetes Mellitus
5
Pulmonary Disease, Chronic Obstructive
4
Lung Neoplasms
4
Depression
4
Constipation
4
Cardiovascular Diseases
4
Weight Loss
3
Stomatitis
3
Renal Insufficiency, Chronic
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Opioid-Induced Constipation
3
Non-alcoholic Fatty Liver Disease
3
Myasthenia Gravis
3
Insulin Resistance
3
Heart Failure
3
Endometrial Hyperplasia
3
Interventions
Hypnosis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Recruiting
×
Pulmonary Disease, Chronic Obstructive
×
Other
×
Clear all
NCT07173348
2026-06-04
HYPNEA
University Hospital, Geneva
Phase NA
Recruiting
82 enrolled
NCT07319039
2026-01-08
BREACH-fMRI
University Hospital, Geneva
Recruiting
16 enrolled
NCT06326957
2025-06-13
SELF-BREATHE
King's College Hospital NHS Trust
Phase NA
Recruiting
246 enrolled
NCT03987633
2025-03-10
EMPOWER
Future Genetics Limited
Recruiting
200,000 enrolled